학술논문
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, aTREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial
Document Type
Journal
Author
Francois, Bruno; Lambden, Simon; Fivez, Tom; Gibot, Sebastien; Derive, Marc; Grouin, Jean-Marie; Salcedo-Magguilli, Margarita; Lemarie, Jeremie; De Schryver, Nicolas; Jalkanen, Ville; Hicheur, Tarik; Garaud, Jean-Jacques; Cuvier, Valerie; Ferrer, Ricard; Bestle, Morten; Pettila, Ville; Mira, Jean-Paul; Bouisse, Camille; Mercier, Emmanuelle; Vermassen, Joris; Huberlant, Vincent; Vinatier, Isabelle; Anguel, Nadia; Levy, Mitchell; Laterre, Pierre-Francois; ASTONISH Invest
Source
Subject
Language
English
ISSN
22132600